This document discusses essential medicines and the concept of "P drugs". It defines essential medicines as those that satisfy the priority health care needs of most populations. The World Health Organization publishes an Essential Medicines List every two years that includes efficacious, safe, and cost-effective medicines for priority conditions. National governments also publish their own lists. Medicines are categorized as primary, secondary, or tertiary based on the level of health care needed. Choosing a "P drug" involves defining the diagnosis, treatment objective, listing effective drug groups, and selecting the most effective, suitable, safe, and affordable drug within the chosen group for treating a condition.
If you are marketing your product in India you should comply these area of regulation.We give Services in getting manufacturing licences
ACCREDITED CONSULTANTS PVT.LTD
info@acplgroupindia.co.in
+919310040434
If you are marketing your product in India you should comply these area of regulation.We give Services in getting manufacturing licences
ACCREDITED CONSULTANTS PVT.LTD
info@acplgroupindia.co.in
+919310040434
Pharmacovigilance is science of detection,
assessment, reporting and prevention of adverse
reactions to drug(s).
Major aims of pharmacovigilance are:
1. Early detection of hitherto unknown adverse
reactions and interactions
2. Detection of increases in frequency of (known)
adverse reactions
3. Identification of risk factors and possible
mechanisms underlying adverse reactions
4. Estimation of quantitative aspects of benefit/risk
analysis and dissemination of information needed to
improve drug prescribing and regulation.
Introduction To Pharmacoeconomics, Objectives, Need of Pharmacoecomics, Four methods of Pharmaeconomics Evaluation, Basic Terminology, Importance of
Pharmacoeconomics.
EBM Is the ability to access, asses and apply the best evidence from systematic research information to daily clinical problems after integrating them with the physician's experience and patient's value.
General Pharmacology Lecture Slides on Essential Drugs and Rational use of Medicines by Sanjaya Mani Dixit Assistant Professor of Pharmacology at Kathmandu Medical College
Pharmacovigilance is science of detection,
assessment, reporting and prevention of adverse
reactions to drug(s).
Major aims of pharmacovigilance are:
1. Early detection of hitherto unknown adverse
reactions and interactions
2. Detection of increases in frequency of (known)
adverse reactions
3. Identification of risk factors and possible
mechanisms underlying adverse reactions
4. Estimation of quantitative aspects of benefit/risk
analysis and dissemination of information needed to
improve drug prescribing and regulation.
Introduction To Pharmacoeconomics, Objectives, Need of Pharmacoecomics, Four methods of Pharmaeconomics Evaluation, Basic Terminology, Importance of
Pharmacoeconomics.
EBM Is the ability to access, asses and apply the best evidence from systematic research information to daily clinical problems after integrating them with the physician's experience and patient's value.
General Pharmacology Lecture Slides on Essential Drugs and Rational use of Medicines by Sanjaya Mani Dixit Assistant Professor of Pharmacology at Kathmandu Medical College
The WHO Model Lists of Essential Medicines are updated every two years by the Expert Committee on Selection and Use of Essential Medicines.
The first Essential Medicines List was published in 1977, and the first Essential Medicines List for Children was published in 2007.
The current versions, updated in September 2021, are the 22nd Essential Medicines List (EML) and the 8th Essential Medicines List for Children (EMLc).
This lecture slides are prepared for Refresher course for pharmacist. Essential Medicines, Rational use of drugs and Self medication, These are the topics covered in this ppt.These slides are also useful for other medical undergraduates and post graduates students.
National List of Essential Medicines of Indiaspmdoc
NLEM, or the National List of Essential Medicines, is a crucial tool in prioritizing healthcare needs and guiding decision-making in the pharmaceutical sector. It includes a list of vital drugs deemed necessary for the population's healthcare, focusing on efficacy, safety, and cost-effectiveness.
The National List of Essential Medicines (NLEM) outlines the essential medications that are vital for addressing the priority health needs of the population. It plays a crucial role in ensuring the availability and accessibility of essential medicines in primary health care services.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Eml p drug
1. SMS MEDICAL COLLEGE, JAIPUR
PRINCIPLES OF ESSENTIAL MEDICINE
LIST AND CONCEPT OF ‘P’ DRUG
-DR.JAYA DADHICH
2. LEARNING OBJECTIVES
• Defining essential medicines
• Origin of concept of essential medicines
• History of essential medicine list
• Parts of essential medicine list
• How to choose essential medicines
• Good prescribing practises
• Rationality of use of drugs
• P DRUG concept
• How to choose a P drug
3. Definition
• As per WHO 1975
“The Essential Drugs are those drugs that
satisfy healthcare needs of the majority of the
population and which should, therefore, be
available at all times, in adequate amounts
and in appropriate dosage forms.”
• As per WHO 2002
“That satisfy the priority health care needs of
the population”
6. 1975- Only a handful of drugs are required to treat
most of the diseases, in most of the people for most of
the times….
According to WHO directives such drugs should be
available in all hospitals at all times…..
7. • 1977 first model of Essential drug list was
published by WHO which included 208 active
substances.
• The EML is updated and revised every two
years by the WHO Expert Committee on the
Selection and Use of Essential Medicines
• 2003 term “Essential Medicine” was used to
replace “Essential Drug.”
• 2015 19th model of Essential medicine list was
published
• 2017 Latest 20th essential medicine list has
been published which includes 433 drugs.
9. The Essential Medicines Target
S S
All the drugs
in the world
Registered medicines
National list of
essential medicines
Levels of use
Supplementary
specialist
medicines
CHW
dispensary
Health center
Hospital
Referral hospital
Private sector
Selection
12. Parts of Essential medicine list
• The core list presents a list of minimum
medicine needs for a basic health-care system,
listing the most efficacious, safe and cost–
effective medicines for priority conditions.
Priority conditions are selected on the basis of
current and estimated future public health
relevance, and potential for safe and cost-
effective treatment.
13. • The complementary list presents essential
medicines for priority diseases, for which
specialized diagnostic or monitoring facilities,
and/or specialist medical care, and/or specialist
training are needed.
In case of doubt medicines may also be listed as
complementary on the basis of consistent higher
costs or less attractive cost effectiveness in a
variety of settings.
14. • In India NATIONAL LIST OF ESSENTIAL MEDICINES
(NLEM) was first released in 1996 and revised in
2003.
• There were 348 medicines listed in NLEM 2011. A
total of 106 medicines have been added, and 70
medicines have been deleted to prepare NLEM
2015 which now contains a total of 376
medicines.
15.
16. • Medicines in NLEM are listed with reference
to the levels of healthcare, namely
a) Primary (P)
b) Secondary (S)
c) Tertiary (T).
There are 209 medicine formulations listed
for all levels of health care (P, S, T), 115
medicine formulations for secondary and
tertiary levels (S, T) and 79 medicine
formulations for the tertiary level (T)
18. Criterias for deletion of a medicine
• Medicine has been banned
• Medicine with better efficacy and safety
profile is available
• Disease burden is no longer a national health
concern
• In case of antimicrobials resistance pattern
has rendered the drug ineffective
• Reports of serious side effects
19.
20.
21.
22.
23.
24. • In short rational use of drugs is based on Rule of
Right
1. Right drug to
2. Right patient
3. In Right dosage
4. At a Right cost
5. With the Right documentation
• SANE criteria which means that Safety,
Affordability, Need and Efficacy should always
be considered.
25.
26. ‘P’ Drug
• P drug means preferred drug or personal drug
• Every doctor should choose his P drug to treat a
particular disease
• Steps in choosing a P drug are
i. Define the diagnosis
ii. Specify the therapeutic objective
iii. Make a list of effective group of drug
iv. Choose an effective group by comparing
efficacy, suitability, safety, and cost of treatment
v. Choose a P drug from effective group of drug
27. Example
1. Stable angina pectoris-final diagnosis according to
presentation and investigations
2. Aim of therapy will be…quick relief from pain
by increasing oxygen supply or by reducing the oxygen
demand
difficult to increase the oxygen supply in case of
arteriosclerotic occlusion so to reduce demand we can
• Decrease preload or
• Decrease contractility or
• Decrease heart rate or
• Decrease the afterload
28. 3. List of Effective group of drugs
• Nitrates
• Calcium channel blockers
• Beta blockers
4. Choosing an effective group
• Efficacy
• Safety side effects
• Suitability dosage forms
• Cost of treatment
29. 5. Choose a P drug from effective group
according to efficacy, safety, suitability, cost
Sublingual Nitroglycerine 1 mg
Isosorbide dinitrate